Please login to the form below
biologic
This page shows the latest biologic news and features for those working in and with pharma, biotech and healthcare.
Lilly extends range of cut-price insulins in the US
biologics including insulin as well as intravenous drugs and controlled substances.
Latest news
-
Boehringer Ingelheim to manufacture first biologic in China under new reforms
German pharma will manufacture BeiGene's PD-1 inhibitor. German pharma Boehringer Ingelheim will be the first company in China to manufacture a biologic, under new regulations aimed at accelerating the
-
The year in review
The Alzheimer’s community is looking towards a big year in 2020 with the late-year news that Biogen will submit a Biologics License Application for aducanumab and the news that
-
Takeda’s subcutaneous Entyvio formulation faces FDA rejection
biologics license application”.
-
FDA follows EMA with approval of Merck’s Ebola vaccine
the FDA’s Center for Biologics Evaluation and Research.
-
Trump administration advances drug importation plan
The plan was initially announced back in July, and would allow the import of certain categories of lower cost drugs from Canada – but would exclude all biologic drugs (including insulin), intravenous
More from news
Approximately 18 fully matching, plus 567 partially matching documents found.
Latest Intelligence
-
The long and winding road to asthma breakthroughs
Respiratory biologics are booming thanks to scientists who refused to be derailed by early research setbacks. ... Biologics are exquisite in what they can do,” he said. “But it wasn’t that obvious 20 years ago.
-
A snapshot of Crescendo Biologics
The company is based in Cambridge, UK, which is renowned for its antibody and biologics research and expertise, making it a prime location for Crescendo’s work. ... Cambridge, UK is probably the leading antibody and biologics development location in
-
The Golden Goose
Ten years ago, around the time the Affordable Care Act, ie, Obamacare, became law, Congress passed the Biologics Price Competition and Innovation (BPCI) Act, hoping it would do for biologics what ... And they tend to be priced closely to their competitors
-
Encouraging signs in biomarker R&D
B-MS withdrew its supplemental Biologics License Application (sBLA) in January this year, explaining that ‘further evidence on the relationship between TMB and PD-L1 is required to fully evaluate the
-
25 Women Leaders in UK Healthcare
That’s why Theodora Hall taking on the top job at emerging UK biotech Crescendo Biologics is worth noting, as she represents a new generation of leaders in the sector.
More from intelligence
Approximately 5 fully matching, plus 77 partially matching documents found.
Latest appointments
-
New hires at FibroGen, Saniona and Turbine
Tuna currently serves as chief scientific officer at Adaptate Biotherapeutics, and has over 15 years of experience in biologics drug discovery and development.
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Bahija has more than 25 years of international leadership experience within the pharmaceutical industry, and joins Immunocore from AstraZeneca, where she has served as President of MedImmune, its global biologics research ... A champion for science and
-
BMS appoints new commercial leader, Davies joins Eisai and more
Commenting on her appointment, Schuermans said: “Sobi has unique capabilities, a heritage in biologics manufacturing, development and supply, and a very exciting future within the rare disease space.
-
Industry appointments
Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early development and the first-in-human trial of a TCR based biologic targeting a melanoma
-
Nabriva Therapeutics appoints chief medical officer
medical affairs for small molecules and biologics.
More from appointments
Approximately 7 fully matching, plus 47 partially matching documents found.
Latest from PMHub
-
Innovative pricing and contracting options
3. For new entrants in the biologics space, adopting net pricing options is crucial since some US payers are volume sensitive and may prefer an older competitor drug that is clinically
-
MIT reveals new pill to deliver insulin
Alex:This device enables the delivery of all biologic drugs, not just insulin. ... For example, I confirmed the insulin was still active when pressed into the device and ensured the properties didn’t change considering that we are submitting the
-
Infographic: Rheumatoid arthritis (RA)
An overview of the RA biologic patient. Our RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study.
-
Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)
It is easy to perform and is more rapid than traditional chemical or biologic cell transfection techniques. ... does not negatively alter the biologic structure or function of the target cells.
-
News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)
A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter.
More from PMHub
Approximately 7 fully matching, plus 38 partially matching documents found.
Featured jobs
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
-
Consultant
-
competitive salary
-
Vice President
-
Competitive Salary Offered
- Account Director or Senior Account Director
-
Salary TBC
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
Subscribe to our email news alerts
- NantKwest rockets on promising pancreatic cancer data
- NantKwest rockets on promising pancreatic cancer data
- NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata
- Novo Nordisk gets MACE prevention claim for Ozempic in US
- Lilly will aim for one $1bn-$5bn deal per quarter in 2020
- Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer
- Lucid Group names Neil Flash chief commercial officer
- New hires at bluebird bio, BioNTech and Provention Bio
- IGNIFI expands healthcare team with two new hires
- W2O acquires advertising and medical education agency 21GRAMS
- FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma
- EU group calls for 'targeted actions' to mitigate impact of Brexit
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- White Paper for download - Explaining the price of your product
- In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
- OPEN Health expands offering with the launch of a new Learning & Development specialist team
- Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
- The changing nature of approvals – what does the future hold?
- The 2019 CMR International Pharmaceutical R&D Factbook...
Quick links
Infographics
